SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-242723
Filing Date
2018-08-08
Accepted
2018-08-08 16:06:00
Documents
3
Period of Report
2018-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d571523d8k.htm 8-K 16274
2 EX-99.1 d571523dex991.htm EX-99.1 54824
3 GRAPHIC g571523snap0001.jpg GRAPHIC 3580
  Complete submission text file 0001193125-18-242723.txt   77448
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38096 | Film No.: 181001353
SIC: 2834 Pharmaceutical Preparations